RHEACELL and AOP Health: Strategic partnership to deliver breakthrough therapies for the "butterfly children’s disease" and ...

RHEACELL announced today that it has entered into an exclusive partnership agreement with the AOP Health Group, who will ...

This approval marks Abeona's entry into the commercial gene therapy market for dystrophic epidermolysis bullosa. LAS VEGAS, May 22, 2025 /PRNewswire/ -- Dystrophic epidermolysis bullosa (DEB ...

After losing 10-month-old Elliana to Epidermolysis Bullosa, her family and supporters raised $24K and awareness through a memorial walk in Maine.

Geneva, Switzerland Saturday, May 24, 2025, 15:30 Hrs [IST] ...

Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...

On Saturday, May 24, a memorial walk was held in honor of Elliana Rose Campbell, a baby girl from Brewer who fought a courageous fight against ...

This approval marks Abeona's entry into the commercial gene therapy market for dystrophic epidermolysis bullosa. The approval was granted based on results from the Phase III VIITAL study ...